Insulin alters nuclear factor-κB and peroxisome proliferator-activated receptor-γ protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells

In both type 2 diabetes and insulin-resistance syndromes, hyperglycemia and advanced glycation end products (AGES) activate the transcription factor nuclear factor-kappa B (NF-kappa B) through a mechanism that partly involves the generation of reactive oxygen species (ROS). The contribution of hyperinsulinemia in this sequence has not been completely elucidated. In this work we investigated the actions of insulin and PPAR-gamma on the stimulation by AGEs of NF-kappa B protein expression in cultured aortic vascular smooth-muscle cells (VSMCs) from non-insulin-dependent diabetic rats and nondiabetic rats. The expression of proteins was evaluated with the use of Western immunoblotting. Incubations (24 hours) of VSMCs with 10 to 100 mu g/mL glycated bovine serum albumin (AGE-BSA) increased NF-kappa B protein expression in both models. PPAR-gamma protein expression was only enhanced at concentrations of 500 to 1000 mu g/mL (AGE-BSA). In the presence of insulin (10-100 nmol/L), the stimulation of NF-kappa B protein expression by AGE-BSA (100 wg/mL) was decreased, whereas the expression of PPAR-gamma protein was enhanced. 15-Deoxyprostaglandin J(2), a direct activator of PPAR-gamma, decreased AGE-BSA-stimulated NF-kappa B expression. These findings suggest that insulin decreases the incidence of alterations in VSMCs induced by AGEs through the reduction of NF-kappa B and an increase in PPAR-gamma protein expression (as far as the model could be extrapolated to in vivo situations). These data may help justify current therapeutic approaches involving the use of insulin and PPAR-gamma agonists.